人工電子耳市場:開發平台報告(開發階段，市場區隔，地區·國家，法規途徑，主要企業)，2023年最新版

Cochlear Implants Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

出版日期: 2023年06月30日 | 出版商:

GlobalData | 英文 55 Pages | 訂單完成後即時交付

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄圖表

本報告提供人工電子耳市場相關調查，提供產品概要與正在開發的開發中產品趨勢，參與企業的最近趨勢等資訊。

Advanced Bionics AG
Advanced Bionics LLC
Auritec Pharmaceuticals Inc
Ceragenix Pharmaceuticals, Inc.
Cochlear Ltd
Demant A/S
Hannover Medical School
Huntington Medical Research Institutes
Labyrinth Devices
MED-EL Elektromedizinische Gerate Gesellschaft mbH
Naval Information Warfare Center Pacific
Northwestern University
OtoKinetics Inc
Sonova Holding AG
Tel Aviv Sourasky Medical Center
Trinity College Dublin
University of Michigan Pediatric Device Consortium
University of Utah
University of Wisconsin Madison

第6章人工電子耳- 最近的開發

第7章附錄

簡介目錄圖表

Product Code: GDME1556EPD

Abstract

GlobalData's Medical Devices sector report, "Cochlear Implants Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the Cochlear Implants pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

A Cochlear Implant (CI) Bionic ear is a device that can be surgically implanted into a person's cochlea to stimulate it to enhance or restore hearing.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Cochlear Implants under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Cochlear Implants and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Cochlear Implants under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product's current stage of development, territory and estimated launch date

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 Cochlear Implants Overview

3 Products under Development

3.1 Cochlear Implants - Pipeline Products by Stage of Development
3.2 Cochlear Implants - Pipeline Products by Territory
3.3 Cochlear Implants - Pipeline Products by Regulatory Path
3.4 Cochlear Implants - Pipeline Products by Estimated Approval Date
3.5 Cochlear Implants - Ongoing Clinical Trials

4 Cochlear Implants - Pipeline Products under Development by Companies

4.1 Cochlear Implants Companies - Pipeline Products by Stage of Development
4.2 Cochlear Implants - Pipeline Products by Stage of Development

5 Cochlear Implants Companies and Product Overview

5.1 Advanced Bionics AG Company Overview
- 5.1.1 Advanced Bionics AG Pipeline Products & Ongoing Clinical Trials Overview
5.2 Advanced Bionics LLC Company Overview
- 5.2.1 Advanced Bionics LLC Pipeline Products & Ongoing Clinical Trials Overview
5.3 Auritec Pharmaceuticals Inc Company Overview
- 5.3.1 Auritec Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 Ceragenix Pharmaceuticals, Inc. (Inactive) Company Overview
- 5.4.1 Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.5 Cochlear Ltd Company Overview
- 5.5.1 Cochlear Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.6 Demant A/S Company Overview
- 5.6.1 Demant A/S Pipeline Products & Ongoing Clinical Trials Overview
5.7 Hannover Medical School Company Overview
- 5.7.1 Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview
5.8 Huntington Medical Research Institutes Company Overview
- 5.8.1 Huntington Medical Research Institutes Pipeline Products & Ongoing Clinical Trials Overview
5.9 Labyrinth Devices Company Overview
- 5.9.1 Labyrinth Devices Pipeline Products & Ongoing Clinical Trials Overview
5.10 MED-EL Elektromedizinische Gerate Gesellschaft mbH Company Overview
- 5.10.1 MED-EL Elektromedizinische Gerate Gesellschaft mbH Pipeline Products & Ongoing Clinical Trials Overview
5.11 Naval Information Warfare Center Pacific Company Overview
- 5.11.1 Naval Information Warfare Center Pacific Pipeline Products & Ongoing Clinical Trials Overview
5.12 Northwestern University Company Overview
- 5.12.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
5.13 OtoKinetics Inc Company Overview
- 5.13.1 OtoKinetics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.14 Sonova Holding AG Company Overview
- 5.14.1 Sonova Holding AG Pipeline Products & Ongoing Clinical Trials Overview
5.15 Tel Aviv Sourasky Medical Center Company Overview
- 5.15.1 Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview
5.16 Trinity College Dublin Company Overview
- 5.16.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview
5.17 University of Michigan Pediatric Device Consortium Company Overview
- 5.17.1 University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview
5.18 University of Utah Company Overview
- 5.18.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview
5.19 University of Wisconsin Madison Company Overview
- 5.19.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview

6 Cochlear Implants- Recent Developments

6.1 Mar 02, 2023: Katya Kruglova to join Sonova's Management Board as GVP Human Resources & Communications
6.2 Dec 20, 2022: Advanced Bionics to pay over $12 million for alleged false claims for cochlear implant processors
6.3 Dec 20, 2022: Advanced Bionics to pay over $12 million for alleged false claims for cochlear implant processors
6.4 Dec 06, 2022: Use of hearing aids and cochlear implants associated with a decreased risk of developing dementia
6.5 Nov 14, 2022: Sonova Holding First half results 2022/23
6.6 Oct 11, 2022: SONOVA HOLDING AG Announces Investor & Analyst Day 2022
6.7 Oct 11, 2022: Sonova Investor & Analyst Day 2022 Leading innovation and further expanding our reach